【ChiCTR1800018817】Effects of immersive virtual reality intervention on pain and anxiety among pediatric patients undergoing venipuncture: A randomized controlled trial
ChiCTR1800018817
尚未开始
/
/
/
2018-10-11
/
/
Patients undergoing venipuncture
Effects of immersive virtual reality intervention on pain and anxiety among pediatric patients undergoing venipuncture: A randomized controlled trial
Effects of immersive virtual reality intervention on pain and anxiety among pediatric patients undergoing venipuncture: A randomized controlled trial
To compare the effects of immersive virtual reality intervention on pain, anxiety stress and length of procedure among pediatric patients, compared to standard care; To evaluate the satisfaction level of healthcare providers on the venipuncture procedure; To evaluate the cost-effectiveness of immersive virtual reality intervention.
随机平行对照
其它
stratified permuted block randomization with a block size of 10. A sequence of grouping identifiers (I=intervention group or C=control group) will be prepared in advance by an independent statistician, using computer-generated random codes for each of the two strata of age group.
未说明
Early Career Scheme
/
100
/
2019-01-01
2020-12-31
/
(1) aged between 4 and 12 years; (2) scheduled to undergo venipuncture; and (3) can understand Chinese and follow instructions.；
请登录查看(1) identified cognitive and learning problems in their medical record; (2) sensory impairment to pain (such as spinal bifida); (3) identified contact precautions; and (4) previous history of seizures or motion sickness.；
请登录查看香港中文大學那打素護理學院
/
香港中文大學那打素護理學院的其他临床试验
- 園藝活動減低香港年輕人憂鬱程度計劃
- 沉浸式虛擬實境干預措施對預防和控制接受首次化療的兒童癌症患者焦慮，噁心和嘔吐之影響: 隨機分組對照研究
- Effects of immersive virtual reality for preventing and managing anxiety, nausea and vomiting among paediatric cancer patients receiving their first chemotherapy: An exploratory trial
- 翻譯財務毒性綜合評分量表為中文版及對癌症病人的信效度測試
- Effects of immersive virtual reality intervention on pain and anxiety among pediatric patients undergoing venipuncture: A randomized controlled trial
- Effects of immersive virtual reality intervention on pain and anxiety among paediatric cancer patients undergoing peripheral intravenous cannulation: A randomized controlled trial
- 探討中度認知障礙及中度腦退化症患者及其照顧者參與優勢取向計劃後 在改善與健康相關之生活質素的成效之研究
- Main study: Effects of a Group- plus Home-based Tai Chi Program on Improving Physical Function and Psychosocial Well-being in Patients with Coronary Heart Disease
- 應用程式輔助個人化自我症狀管理的隨機對照研究
- An educational program for Hong Kong Chinese post-menopausal women
- 沉浸式虛擬實境干預措施對兒童接受靜脈導管程序的有效性研究
- Effects of a Group- plus Home-based Tai Chi Program on Improving Physical Function and Psychosocial Well-being in Patients with Coronary Heart Disease
- 伴音樂節奏的體育活動對冠心病患者心臟康復的效果研究
- 探討有效改善社區中共病長者疲憊的方法
香港中文大學那打素護理學院的其他临床试验
- 以理論為基礎的跨專業教育計劃，以提高香港華人社區長者的新冠疫苗接種率
- 園藝活動減低香港年輕人憂鬱程度計劃
- 基于微信的夫妻心理社会干预对妇科肿瘤患者和其配偶在性功能，关系满意度和生活质量的影响研究
- Effects of immersive virtual reality intervention on pain and anxiety among pediatric patients undergoing venipuncture: A randomized controlled trial
- Main study: Effects of a Group- plus Home-based Tai Chi Program on Improving Physical Function and Psychosocial Well-being in Patients with Coronary Heart Disease
- 應用程式輔助個人化自我症狀管理的隨機對照研究
- Effects of a Group- plus Home-based Tai Chi Program on Improving Physical Function and Psychosocial Well-being in Patients with Coronary Heart Disease
最新临床资讯
-
Nat Rev Clin Oncol｜AI赋能肿瘤临床试验：从流程优化到证据生成的全景透视
智药邦2026-08-12
-
康臣药业1类新药糖肾方“芪箭颗粒”获NMPA临床研究许可
康臣药业2026-08-12
-
璎黎药业2026-08-12
-
幂方健康基金2026-08-12
-
细胞与基因治疗领域2026-08-12
-
云南白药2026-08-12
-
细胞治疗前沿2026-08-12
-
广州达博生物制品有限公司2026-08-12
-
医药笔记2026-08-12
-
医药笔记2026-08-12
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 20 8
-
摩熵咨询 34 27
-
摩熵咨询 20 5
-
颁布机构：四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构：国家医保局 2026-07-31
-
颁布机构：国家药品审评中心（CDE） 2026-07-24
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 35 36
-
摩熵咨询 28 38
-
摩熵咨询 34 18
-
颁布机构：国家市场监督管理总局 2026-08-10
-
颁布机构：国家市场监督管理总局 2026-05-29
-
颁布机构：国家市场监督管理总局 2026-05-29